Rosalind Advisors, Inc. - Significant Ownership

Signature - Title
Steven Salamon - President, Rosalind Advisors, Inc.
Location
Toronto, Ontario, Canada
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Rosalind Advisors, Inc..

Significant Ownership of Rosalind Advisors, Inc.

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
DCTH DELCATH SYSTEMS, INC. Common Shares 9.9% $78.7M 6.66M Rosalind Advisors, Inc. Dec 23, 2024
MYO MYOMO, INC. Common Shares 9.9% $38.4M 7.57M Rosalind Advisors, Inc. Dec 31, 2024
NSPR InspireMD, Inc. Common Shares 9.9% $28.5M 9.93M Rosalind Advisors, Inc. Dec 31, 2024
PYPD PolyPid Ltd. Common Shares 9.9% $11.7M 4.08M Rosalind Advisors, Inc. Dec 31, 2024
BFRI Biofrontera Inc. Common Shares 9.9% $9.46M 9.96M Rosalind Advisors, Inc. Dec 31, 2024
TLPH TALPHERA, INC. Common Shares 9.9% $4.28M 7.64M Rosalind Advisors, Inc. Mar 31, 2025
CLRB Cellectar Biosciences, Inc. Common Shares 9.9% $3.06M 7.47M Rosalind Advisors, Inc. Dec 31, 2024
KPRX KIORA PHARMACEUTICALS INC Common Shares 9.9% $129K 715K Rosalind Advisors, Inc. Dec 31, 2024
OPTN OptiNose, Inc. Common Shares 8.7% $5.21M 965K Rosalind Advisors, Inc. Dec 31, 2024
MDWD MediWound Ltd. Common Shares 7.2% $1.15M 791K Rosalind Advisors, Inc. Dec 31, 2024
TRVI Trevi Therapeutics, Inc. Common Shares 1.2% $6.45M 1.06M Rosalind Advisors, Inc. Feb 13, 2025
SPRB SPRUCE BIOSCIENCES, INC. Common shares 0% $0 0 Rosalind Advisors, Inc. Dec 31, 2024

Schedules 13D/G Reported by Rosalind Advisors, Inc.:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.